Aktie A2PD5T BLUEBERRIES MEDICAL CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Blueberries Medical Corp.

Aktien

A2PD5T

CA09609Y1016

BBM

Markt geschlossen - Canadian Securities Exchange
Andere Börsenplätze
 18:46:02 16.05.2024 		% 5 Tage % 1. Jan.
0,02 CAD 0,00 % Intraday Chart für Blueberries Medical Corp. +33,33 % 0,00 %
26.04. Blueberries Medical Corp. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Blueberries Medical Corp. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Blueberries Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
Blueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement
Blueberries Medical Corp. announced that it has received CAD 1.987876 million in funding
Blueberries Medical Announces C$2 Million Non-Brokered Private Placement
Blueberries Medical Corp. announced that it expects to receive CAD 1.987876 million in funding
Blueberries Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Blueberries Medical : PR Blueberries Partnership whit Lab.Nutripharma
Blueberries Medical : SEDAR RETURN CARD
Blueberries Medical : PR Blueberries Partnership whit Lab.Nutripharma
Blueberries Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Blueberries Medical Reports Q1-2023
Blueberries Medical Corp. Announces Board Changes
Blueberries Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Allied Corp. Signs Joint Venture with Blueberries Medical Corp. to Expand Product Offering and Bring Derivative Products to Global Markets
Allied Corp Signs Joint Venture With Blueberries Medical Corp. to Expand Product Offering and Bring Derivative Products to Global Markets
Blueberries Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Blueberries Medical Corp. Auditor Raises 'Going Concern' Doubt
Blueberries Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Blueberries Medical Corp. announced that it has received CAD 1.47147 million in funding from Terraflos Inc.
Blueberries Medical Reports 2022 Q2 Financial Results and Provides Corporate and Operations Update
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PD5T Aktie
  4. Nachrichten Blueberries Medical Corp.
  5. Andere Sprachen